The Self-Testing Market is valued at USD 6.37 Billion in 2021 and is expected to reach USD 8.80 Billion by 2028 with a CAGR of 4.72% over the forecast period. Increasing number of viral infections and virus-related diseases is one of the major factors driving the growth of the Global Self-Testing Market.
Self–test kits are used for the rapid diagnostic in different diseases. In this test no need of the medical expert. Self-tests are comfortable and convenient as they can be taken at any time and require a small procedure. The self- test kits are used in different condition like, pregnancy self-test, HIV self-test, self-test kits for infertility, self-test kits for STIs and others. The home testing is increasing from 1970 with the pregnancy kit. In the recent years, there are number various kinds of self-testing kits are available in the market. Now these kits are quick and simple tests for ovulation. People can also monitor blood pressure as well as test for HIV, colon cancer, hepatitis C, deteriorating vision, and urinary tract infections. Some products provide results right away, while others are sample collection devices that need to be mailed to a laboratory for processing. Consumers are inclining towards the self-test kit as it’s convenient and gives fast result.
Global Self-Testing Market report is segmented on the basis of product, usage, application, sample, end-user and region & country level. Based upon product type, the market is segmented into diagnostic kits, diagnostic device and diagnostic strips. Based upon usage, the market is divided into disposable and reusable. Based upon application, the market is divided into cholesterol and triglycerides tests, diabetes and glucose tests, blood pressure test, diabetes and glucose test, pregnancy test, urinary tract infection test, STD /STI test fertility test, ovulation test cancer test, transaminase test, thyroid test menopause test, intolerance or celiac disease test, allergy test and anemia test. Based upon sample, the market is divided into the hospital pharmacies, pharmacies and e-commerce.
The regions covered in this Self-Testing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Self -Testing sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Rapid diagnostic tests are highly adopted for diagnosis, patient management, epidemiology, and screening and growing preference for the self-diagnosis of viral diseases are some of the major factors driving the market growth. In addition, increase in the detection of new, infectious viruses is also supplementing the market growth of self-testing market. For example, according to U.S government; approximately 37.9 million people across the globe with HIV/AIDS in 2018. Of these, 36.2 million were adults and 1.7 million were children. However, complex regulatory scenario regarding the approval for diagnostic tests for viral infections and lack of awareness regarding newer self-testing may hamper the market growth during the forecast period. In spite of that, research and development by self-testing manufacturing companies may create the number of opportunities for the further growth of the market.
North America held the largest share of the self-testing market in recent years owing to an increasing number of healthcare sectors adopting these diagnostic kits to detect various infectious diseases caused by bacteria and viruses. Many people in the United States get sick and die from infectious diseases each year. The U.S. and Canada are the major contributors for the growth of the regional market. North America’s market includes productive government regulatory support for encouraging domestic level private investment, which is likely to be a significant factor for the region’s growing healthcare industry. Asia pacific is emerging region in self-testing market due to the increasing population and awareness about health in this region.
March 19th, 2020; Everlywell announces that an at-home collection kit with telehealth diagnosis for COVID-19 will be available to for USD 139. The initial offering of 30,000 collection kits will significantly impact total coronavirus testing capacity in the United States; free telehealth consults are included for those with positive results. By working with multiple labs to scale infrastructure, the company plans to have testing and diagnosis capacity for a quarter of a million people weekly.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD 6.37 Billion|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 8.80 Billion|
|Tables, Charts & Figures:||175|
|Self-Testing Market Players||PRIMA Lab SA., bioLytical Laboratories Inc., SelfDiagnostics OÜ, OraSure Technologies, Inc, Nectar Lifesciences Limited, Piramal Enterprises, Cardinal Health, Accuquik, Geratherm Medical AG, Johnson & Johnson, B. Braun Holding GmbH, and others.|
|Segments Covered||By Product, By Usage, By Application, By Sample, By End- User|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|